Thermo Fisher Scientific
In AKO Capital's portfolio · London
Ticker TMO
Not in the portfolio as of Q3 2026. Every quarter it shows up in a London 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2025 | Sell | 0 | |
| Q2 2025 | Reduce 92% | 26,427 | 0.1% |
| Q1 2025 | Add 6% | 332,845 | 2.1% |
| Q4 2024 | Reduce 26% | 313,784 | 2.3% |
| Q3 2024 | Reduce 19% | 423,473 | 3.4% |
| Q2 2024 | Add 14% | 524,248 | 4.0% |
| Q1 2024 | Add 181% | 460,183 | 3.8% |
| Q4 2023 | Reduce 52% | 163,937 | 1.2% |
| Q3 2023 | Reduce 2% | 338,427 | 2.8% |
| Q2 2023 | Reduce 44% | 345,573 | 2.7% |
| Q1 2023 | Reduce 5% | 614,284 | 5.4% |
| Q4 2022 | Reduce 30% | 647,343 | 5.8% |
| Q3 2022 | Reduce 24% | 924,031 | 7.7% |
| Q2 2022 | No change | 1,212,500 | 9.2% |
| Q1 2022 | Reduce 2% | 1,206,538 | 7.7% |
| Q4 2021 | Add 8% | 1,229,899 | 8.0% |
| Q3 2021 | Add 16% | 1,142,461 | 6.8% |
| Q2 2021 | Add 34% | 984,437 | 5.6% |
| Q1 2021 | Add 39% | 735,859 | 4.2% |
| Q4 2020 | Add 22% | 529,274 | 3.2% |
| Q3 2020 | Buy | 435,377 | 3.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.